Abstract
No public abstract is available from the verified source records.
Katie J. McMenamin, Anya Sanchorawala, Shabatun Jamila Islam, Tatiana B. Prokaeva, Brian Spencer, Sergio Luis Teruya, Jeremy A. Slivnick, Rabah S Alreshq, Denise M. Fine, Stephen T. Helmke, CESIA GALLEGOS, Mathew S. Maurer, Frederick L. Ruberg
Abstract
Authors
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Cardiac amyloidosis due to transthyretin protein
10.1001/jama.2024.0442 · 2024
Transthyretin amyloid cardiomyopathy: JACC State-of-the-Art Review
10.1016/j.jacc.2019.04.003 · 2019
Association of transthyretin Val122Ile variant with incident heart failure among Black individuals
10.1001/jama.2022.2896 · 2022
Current and evolving multimodality cardiac imaging in managing transthyretin amyloid cardiomyopathy
10.1016/j.jcmg.2023.10.010 · 2024
Transthyretin cardiac amyloidosis in older Black and Hispanic individuals with heart failure
10.1001/jamacardio.2025.2948 · 2025
Nonbiopsy diagnosis of cardiac transthyretin amyloidosis
10.1161/circulationaha.116.021612 · 2016
Early detection of transthyretin cardiac amyloidosis using 124i-evuzamitide positron emission tomography/computed tomography
10.1016/j.jcmg.2025.01.018 · 2025
Determinants of transthyretin levels and their association with adverse clinical outcomes among UK Biobank participants
10.1038/s41467-024-50231-1 · 2024
Institutions
Provenance
crossref
Confidence 100%
ror
Confidence 99%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
openalex
Confidence 95%
datacite
Confidence 0%
No additional external references are available.